CGNSF - Cognetivity Neurosciences Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
1/30/2019
1/30/2018
1/30/2017
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
625
732
82
63
Selling General and Administrative
2,819
3,476
1,410
413
Total Operating Expenses
3,449
4,212
1,494
477
Operating Income or Loss
-3,449
-4,212
-1,494
-477
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-1
-2
-7
18
Income Before Tax
-3,442
-4,193
-1,496
-459
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-3,442
-4,193
-1,496
-459
Net Income
-3,442
-4,193
-1,496
-459
Net Income available to common shareholders
-3,442
-4,193
-1,496
-459
Reported EPS
Basic
-
-0.10
-0.05
-0.02
Diluted
-
-0.10
-0.05
-0.02
Weighted average shares outstanding
Basic
-
40,411
29,557
22,686
Diluted
-
40,411
29,557
22,686
EBITDA
-
-4,208
-1,493
-477